2016
DOI: 10.1016/j.biopha.2015.11.001
|View full text |Cite
|
Sign up to set email alerts
|

The stimulatory effects of eNOS/F92A-Cav1 on NO production and angiogenesis in BMSCs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 25 publications
0
8
0
Order By: Relevance
“…Cav-1 F92A , which attenuates the inhibition of eNOS activity, enhances the production of NO. Moreover, it has been demonstrated the stimulatory effects of Cav-1 F92A on angiogenesis in rBMSCs via improving NO production, which may provide a novel treatment for PAH [17]. We hypothesized that in rats with MCT-induced PAH, the administration of rBMSC/Cav-1 F92A may ameliorate vascular resistance and restore pulmonary hemodynamics by inhibiting excessive oxidative stress.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Cav-1 F92A , which attenuates the inhibition of eNOS activity, enhances the production of NO. Moreover, it has been demonstrated the stimulatory effects of Cav-1 F92A on angiogenesis in rBMSCs via improving NO production, which may provide a novel treatment for PAH [17]. We hypothesized that in rats with MCT-induced PAH, the administration of rBMSC/Cav-1 F92A may ameliorate vascular resistance and restore pulmonary hemodynamics by inhibiting excessive oxidative stress.…”
Section: Discussionmentioning
confidence: 99%
“…rBMSC isolation, culture, lentiviral vector (LV) packaging, and transduction were all performed as previously described [17]. Briefly, rBMSCs (passage 3) in the exponential growth phase were randomly divided into five groups: control group, rBMSC/Vector group (transduced with pLVX-mCMV-mCherry lentivirus), rBMSC/Cav-1 group (transduced with LV-Cav-1 lentivirus), rBMSC/Cav-1 F92A group (transduced with LV-Cav-1 F92A lentivirus), and rBMSC/Cav-1 F92A +L-NAME group (transduced with LV-Cav-1 F92A lentivirus and treated with L-NAME (2 mM, Beyotime Biotechnology, Jiangsu, China)).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…S0021; Beyotime Institute of Biotechnology, Haimen, China) according to the manufacturer's protocol. The assay was based on the Greiss test (26). Mice were euthanized, brains (n=5) were quickly removed, and tissues were homogenized in radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology) and centrifuged at 15,000 × g for 15 min at 4°C.…”
Section: Methodsmentioning
confidence: 99%
“…Lentiviral vector packaging and transduction was performed as we described previously with slight modification [ 32 ]. Briefly, lentiviral plasmids expressing ZNF750 gene, together with packaging plasmids pRSV-Rev, VSV-G and psPax2 were co-transfected into 70–80% confluent 293T cells with lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA, USA), according to the manufacturer’s instructions for the generation of LV-ZNF750 lentivirus.…”
Section: Methodsmentioning
confidence: 99%